Praxis Precision Medicines (PRAX) Depreciation and Depletion (2019 - 2026)
Praxis Precision Medicines' quarterly Depreciation and Depletion came in at $39000.0 in Q1 2026, down 17.02% year-on-year from $47000.0 in Q1 2025, and up 425.0% quarter-over-quarter from -$12000.0 in Q4 2025.
Praxis Precision Medicines has reported Depreciation and Depletion for 8 years, with the latest figure at $39000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 17.02% year-over-year to $39000.0; the trailing twelve-month figure through Mar 2026 stood at $92000.0 (down 72.54% YoY), and the FY2025 full-year result was $100000.0, down 75.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $39000.0, up from -$12000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $119000.0 in Q2 2022, with the low at -$12000.0 in Q4 2025.
- Average Depreciation and Depletion over 5 years is $81764.7, with a median of $102000.0 recorded in 2022.
- Year-over-year, Depreciation and Depletion jumped 340.74% in 2022 and sank 113.48% in 2025.
- Tracing PRAX's Depreciation and Depletion over 5 years: stood at $105000.0 in 2022, then gained by 5.71% to $111000.0 in 2023, then declined by 19.82% to $89000.0 in 2024, then slumped by 113.48% to -$12000.0 in 2025, then jumped by 425.0% to $39000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $39000.0 (Q1 2026), -$12000.0 (Q4 2025), and $19000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Praxis Precision Medicines | 10.11 Bn | 9.32 Bn | - | 39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 111,000.00 |
| Dec 31, 2023 | 111,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Jun 30, 2023 | 106,000.00 |
| Mar 31, 2023 | 106,000.00 |
| Mar 31, 2023 | 106,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 102,000.00 |
| Sep 30, 2022 | 102,000.00 |
| Jun 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 119,000.00 |
| Mar 31, 2022 | 93,000.00 |
| Mar 31, 2022 | 93,000.00 |
| Dec 31, 2021 | 111,000.00 |
| Dec 31, 2021 | 111,000.00 |
| Sep 30, 2021 | 39,000.00 |
| Sep 30, 2021 | 39,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | 23,000.00 |
| Mar 31, 2021 | 23,000.00 |
| Dec 31, 2020 | 20,000.00 |
| Dec 31, 2020 | 20,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Jun 30, 2020 | 10,000.00 |
| Jun 30, 2020 | 10,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Dec 31, 2019 | 10,000.00 |
| Dec 31, 2019 | 10,000.00 |